Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Edderd who wrote (10285)	6/30/1998 7:37:00 PM
From: DR.TECH	Read Replies (1) \| Respond to of 23519

Hang in there longs this company is about to be reborn....Major sales approach changes will give quick significant cost reductions and return to profit by 3rd qtr...we also have a upgrade coming...PS. stock would have traded up big this week except MLAM dumped 900k shares during good news to dress his window by quarter end...excuse was fear of viagra, maybe he doesn't read the paper!

To: Edderd who wrote (10285)	6/30/1998 9:14:00 PM
From: VLAD	Read Replies (1) \| Respond to of 23519

Ed, Do you always start your titration at 500 ucgms? Do you have any patients who actually do well on only 125 ucgms? What percentage of your patients need to be bumped up to 1000 ucgms and what percentage do you drop to 250 ucgms? I know....just rough estimates. Just curious.